Oragenics
OGEN
12 hedge funds and large institutions have $10.5M invested in Oragenics in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
37% less capital invested
Capital invested by funds: $16.5M → $10.5M (-$6.07M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$1.69M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$93.7K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$40.2K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$26.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$214K |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$104K |
OGEN Hedge Fund Activity: Q2 2016 in Review
12 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2016, worth a combined $10.5M — down 37% from $16.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Third Security, adding an estimated $1.69M. The largest seller was Fidelity Investments, cutting an estimated $214K.
- 12 institutional investors held Oragenics (OGEN) as of Q2 2016, up from 10 in Q1 2016.
- Funds reported $10.5M of Oragenics stock for Q2 2016, down 37% quarter-over-quarter.
- 3 funds opened new Oragenics positions in Q2 2016 and 1 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q2 2016 was Third Security, an estimated $1.69M added.
- The largest Oragenics seller in Q2 2016 was Fidelity Investments, an estimated $214K sold.
Based on aggregated 13F filings for Q2 2016.